TerumoTRUMY -0.37%92 OCF Margin % is 29.61% as of Mar. 2026, which is 55% above its 10-year median of 19.09. GuruFocus rates TRUMY with a GF Score™ of 92/100 and a GF Value™ of $19.25 (Significantly Undervalued). Among 815 Medical Devices & Instruments companies, Terumo ranks better than 79.75% on this metric.
The historical rank and industry rank for Terumo's OCF Margin % or its related term are showing as below:
TRUMY'
s OCF Margin % Range Over the Past 10 Years
Min: 14.33 Med: 19.09 Max: 20.4
Current: 20.28
During the past 13 years, the highest OCF Margin % of Terumo was 20.40%. The lowest was 14.33%. And the median was 19.09%.
TRUMY's OCF Margin % is ranked better than 79.75% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs TRUMY: 20.28
Terumo OCF Margin % Related Terms
Terumo OCF Margin % Historical Data
* Premium members only.
The historical data trend for Terumo's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Terumo's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Terumo OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Terumo's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Terumo's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terumo (TRUMY) has a OCF Margin % of 29.61% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Terumo and its competitors. This is 55% above median its historical median of 19.09. Over the past decade, Terumo's OCF Margin % has ranged from 14.33 to 20.40. According to the industry distribution chart, Terumo ranks #165 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 20.2%.
Is Terumo's OCF Margin % too high?
Terumo's current OCF Margin % of 29.61% is 55% above median its 10-year median of 19.09. Over the past 10 years, this metric has ranged from a low of 14.33 to a high of 20.40. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Terumo's value of 29.61% is 405.3% above this industry median. Based on the distribution chart, Terumo ranks #165 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Terumo has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terumo's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Terumo ranks #165 out of 815 companies for OCF Margin %. This places Terumo in the top 20% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. Terumo's value of 29.61% is 405.3% above this benchmark. Historically, Terumo's own OCF Margin % has ranged from 14.33 to 20.40 over the past decade. While the company's 10-year median is 19.09 vs. the industry median of 5.86, Terumo has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Terumo's current OCF Margin % of 29.61% is 405.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Terumo and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Terumo's current OCF Margin % is 29.61%, which is 55% above median its own 10-year median of 19.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Based on GuruFocus' analysis, Terumo (TRUMY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.25, compared to a current price of $13.45 — trading 30.1% below its estimated fair value. The current OCF Margin % is 29.61%, which is 55% above median its 10-year median of 19.09 and 405.3% above the Medical Devices & Instruments industry median of 5.86. Terumo's overall GF Score™ is 92/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Terumo (TRUMY), the current OCF Margin % is 29.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Terumo (TRUMY) Overvalued in 2026?
Based on GuruFocus' analysis, Terumo stock appears to be undervalued.
The current stock price of $13.45 is trading 30.1% below its estimated GF Value™ of $19.25.
GuruFocus considers Terumo to be Significantly Undervalued.
Key valuation signals for TRUMY:
OCF Margin %: 29.61% (55% above median its 10-year median of 19.09)
GF Value™: $19.25 vs. price of $13.45 (30.1% below fair value)
Industry Position: 405.3% above the Medical Devices & Instruments median (#165 of 815)
No single metric tells the full story. See the TRUMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
92GF Score
Get the complete analysis for TRUMY
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRUMY has been successfully added to your 
